Maximum Dose of Solifenacin
The maximum recommended dose of solifenacin is 10 mg once daily in patients with normal renal and hepatic function 1.
Standard Dosing
- Starting dose: 5 mg once daily
- Maximum dose: 10 mg once daily
- The dose may be increased from 5 mg to 10 mg if needed for improved symptom control 1
Dose Restrictions in Special Populations
Severe Renal Impairment
Maximum dose is 5 mg once daily in patients with severe renal impairment (creatinine clearance <30 mL/min/1.73 m²) 1. Higher plasma concentrations occur in these patients, increasing the risk of antimuscarinic adverse reactions.
Moderate Hepatic Impairment
Maximum dose is 5 mg once daily in patients with moderate hepatic impairment (Child-Pugh B) 1. Solifenacin plasma concentrations are significantly elevated in these patients.
Severe Hepatic Impairment
Solifenacin is not recommended in patients with severe hepatic impairment (Child-Pugh C) 1.
Clinical Context
The FDA label explicitly states that intolerable antimuscarinic adverse reactions occurred in normal volunteers taking 50 mg daily (5 times the maximum therapeutic dose), and the highest accidental overdose was 280 mg (28 times the maximum dose) 1. This reinforces that 10 mg daily is the therapeutic ceiling.
Research evidence supports the 10 mg dose as effective and well-tolerated, with significantly greater reductions in OAB symptoms compared to 5 mg, though with increased anticholinergic side effects like dry mouth and constipation 2, 3. However, one guideline noted that higher doses (10 mg vs 5 mg) did not decrease UI episode frequency and were associated with increased adverse effects 4.
Important caveat: When combining solifenacin with strong CYP3A4 inhibitors (e.g., ketoconazole 400 mg), the maximum dose should be reduced to 5 mg once daily due to significantly increased drug exposure 1.